NICOLE VITULLO Net Worth - Insider Trades and Bio as of Jun 21, 2026

ESPREsperion Therapeutics, Inc.SEC CIK: 0001196863

Estimated Net Worth

$225 Thousand

Last Updated: May 19, 2026 02:31 AM EST

Transaction Summary

Total Transactions231

Buy-Sell Ratio0.67

Buy Transactions31

Sell Transactions46

Transaction Volume

Total Volume$34.59M

Net Volume$102.27M

Buy Volume$68.43M

Sell Volume-$33.84M

Trade Analysis

AVG Trade Size$55.55K

Largest Trade$10.00M

Most Active MonthMay

Most Active Year2014

Trading Sentiment

OverallBullish

Recent TradeNeutral

Last 90 Days0 Trades

ConvictionNone

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Nicole Vitullo does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, Volcano Corp, Bionano Genomics, Inc., Orexigen Therapeutics, Inc., ZOGENIX, INC., CoLucid Pharmaceuticals, Inc., TANDEM DIABETES CARE INC, MARINUS PHARMACEUTICALS INC, GLAUKOS Corp, VERACYTE, INC., Atara Biotherapeutics, Inc., Aldeyra Therapeutics, Inc., Vanda Pharmaceuticals Inc., Syndax Pharmaceuticals Inc, Esperion Therapeutics, Inc., Clovis Oncology, Inc., NUVASIVE INC, Alliqua BioMedical, Inc., OBALON THERAPEUTICS INC, Evoke Pharma Inc, aTYR PHARMA INC, ALIMERA SCIENCES INC, OTONOMY, INC., Neothetics, Inc., NOVACEA INC, Durata Therapeutics, Inc., Ocera Therapeutics, Inc., CADENCE PHARMACEUTICALS INC, Achaogen Inc, Regado Biosciences Inc, ACHILLION PHARMACEUTICALS INC, Celator Pharmaceuticals Inc, Somaxon Pharmaceuticals, Inc., Northstar Neuroscience, Inc., and ONYX PHARMACEUTICALS INC.

2017 was Nicole Vitullo's most active year for acquiring shares with 6 total transactions. Nicole Vitullo's most active month to acquire stocks was the month of April. 2020 was Nicole Vitullo's most active year for disposing of shares, totalling 10 transactions. Nicole Vitullo's most active month to dispose stocks was the month of December. 2010 saw Nicole Vitullo paying a total of $75,500.00 for 100,000 shares, this is the most they've acquired in one year. In 2020 Nicole Vitullo cashed out on 308,431 shares for a total of $229,515.30, their largest year based on trade value.

Holdings & Transactions

ESPResperion therapeutics, inc.

Updated: Jun 02, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	88.00K	—	—	Jun 02, 2025	88.00K	Grant	—	May 29	View
From 4	—	65.00K	—	—	May 24, 2024	65.00K	Grant	—	May 23	View
From 4	0.82	26.15K	—	—	Jun 16, 2023	57.92K	Grant	—	Jun 15	View
From 4	—	20.00K	—	—	May 27, 2022	20.00K	Grant	—	May 26	View
From 4	0.64	12.38K	—	—	May 28, 2021	31.77K	Grant	—	May 27	View
From 4	0.46	6.11K	—	—	May 29, 2020	19.39K	Grant	—	May 28	View
From 4	0.60	4.97K	—	—	May 31, 2019	13.29K	Grant	—	May 29	View
From 4	-0.99	1.12M	$44.73	-$685.60K	Mar 21, 2019	8.32K	Sale	—	Mar 19 - 21	View
From 4	-0.72	17.63K	—	—	Jun 26, 2018	1.12M	Disposition	—	Jun 22	View
From 4	—	10.10K	—	—	May 25, 2018	10.10K	Grant	—	May 23	View
From 4	-0.44	867.96K	$39.40	-$348.55K	Jan 26, 2018	1.14M	Sale	—	Jan 24 - 26	View
From 4	-0.16	365.21K	$53.85	-$502.21K	Dec 08, 2017	1.94M	Sale	—	Dec 06 - 08	View
From 4	—	14.00K	—	—	Apr 19, 2017	14.00K	Grant	—	Apr 17	View
From 4	—	8.00K	—	—	Jun 13, 2016	8.00K	Grant	—	Jun 09	View
From 4	—	8.00K	—	—	May 15, 2015	8.00K	Grant	—	May 14	View
From 4	-0.14	350.00K	—	—	Mar 24, 2015	2.22M	Disposition	—	Mar 20	View
From 4	0.24	500.00K	$20.00	$10.00M	Oct 21, 2014	2.57M	Purchase	—	Oct 21	View
From 4	—	5.00K	—	—	May 16, 2014	5.00K	Grant	—	May 15	View
From 4	-0.06	140.72K	$14.00	—	Jul 02, 2013	2.17M	Buy-Options	—	Jul 01	View
From 3	—	—	—	—	Jun 25, 2013	21.47K	—	—	—	View

MRNSmarinus pharmaceuticals inc

Updated: Feb 07, 2022VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	4.10	15.13K	—	—	Feb 07, 2022	18.82K	Grant	—	Feb 04	View
From 4	-0.99	632.37K	$15.87	-$67.45K	Mar 16, 2021	3.69K	Sale	—	Mar 12 - 16	View
From 4	—	16.50K	—	—	Jan 20, 2021	16.50K	Grant	—	Jan 15	View
From 4/A	—	150.00K	—	—	Nov 06, 2020	150.00K	Grant	—	Jan 08	View
From 4	—	100.00K	—	—	Jan 10, 2020	100.00K	Grant	—	Jan 08	View
From 4	—	35.00K	—	—	Feb 28, 2019	35.00K	Grant	—	Feb 26	View
From 4	—	—	—	—	Jan 24, 2018	2.54M	Acq/Dis	—	Jan 22	View
From 4	—	35.00K	—	—	Dec 08, 2017	35.00K	Grant	—	Dec 06	View
From 4	—	—	—	—	Sep 11, 2017	2.54M	Acq/Dis	—	Sep 11	View
From 4	4.55	15.00K	—	—	Jan 19, 2017	2.55M	Grant	—	Jan 17	View
From 4	—	11.00K	—	—	Aug 05, 2016	2.55M	Grant	—	Aug 03	View
From 4	—	6.30K	—	—	Jul 22, 2015	6.30K	Grant	—	Jul 20	View
From 4	—	6.00K	—	—	Oct 01, 2014	6.00K	Grant	—	Sep 30	View
From 4	—	—	—	—	Aug 07, 2014	17.00K	Options	—	Aug 05	View
From 4	0.20	419.74K	$8.00	$3.36M	Aug 07, 2014	2.48M	Purchase	—	Aug 05	View
From 3	—	—	—	—	Jul 31, 2014	—	—	—	—	View
From 3	—	—	—	—	Jul 31, 2014	—	—	—	—	View
From 3	—	—	—	—	Jul 31, 2014	42.55K	—	—	—	View

achillion pharmaceuticals inc

Updated: Jan 29, 2020

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	3.73M	$6.30	-$21.77M	Jan 29, 2020	—	Disposition	—	Jan 28	View
From 4	—	42.00K	—	—	Jan 25, 2019	42.00K	Grant	—	Jan 23	View
From 4	-0.35	20.00K	—	—	Jun 04, 2018	3.45M	Disposition	—	May 31	View
From 4	—	30.00K	—	—	Feb 13, 2018	30.00K	Grant	—	Feb 09	View
From 4	-0.34	1.73M	$4.09	$7.94K	Aug 14, 2017	3.47M	Options	—	Aug 10	View
From 4	—	30.00K	—	—	Jan 19, 2017	30.00K	Grant	—	Jan 19	View
From 4	—	30.00K	—	—	Jan 26, 2016	30.00K	Grant	—	Jan 25	View
From 4	-0.19	550.00K	$10.17	-$5.60M	Nov 12, 2015	2.39M	Sale	—	Nov 09 - 11	View
From 4	-0.00	9.31K	$8.22	-$76.53K	Sep 29, 2015	2.94M	Sale	—	Sep 25	View
From 4	-0.90	489.93K	$7.51	-$284.20K	Aug 18, 2015	77.75K	Sale	—	Aug 14 - 18	View
From 4	-0.31	1.48M	—	—	May 22, 2015	3.44M	Disposition	—	May 21	View
From 4	—	25.00K	—	—	Dec 04, 2014	25.00K	Grant	—	Dec 02	View
From 4	-0.19	1.10M	—	—	Sep 11, 2014	4.92M	Disposition	—	Sep 09	View
From 4	—	25.00K	—	—	Dec 19, 2013	25.00K	Grant	—	Dec 17	View
From 4	-0.14	933.54K	—	—	Jan 18, 2013	6.02M	Disposition	—	Jan 18	View
From 4	—	20.00K	—	—	Dec 20, 2012	20.00K	Grant	—	Dec 18	View
From 4	-0.14	1.11M	—	—	Jun 04, 2012	6.95M	Disposition	—	May 31	View
From 4	—	20.00K	—	—	Dec 14, 2011	20.00K	Grant	—	Dec 12	View
From 4	—	50.00K	—	—	Dec 20, 2010	50.00K	Grant	—	Dec 16	View
From 4	—	—	$3.02	$75.50K	Oct 08, 2010	25.00K	Options	—	Oct 06	View
From 4	—	25.00K	—	—	Oct 04, 2010	25.00K	Grant	—	Sep 30	View
From 3	—	—	—	—	Aug 23, 2010	8.03M	—	—	—	View

alliqua biomedical, inc.

Updated: May 13, 2019

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	May 13, 2019	22.53K	—	—	—	View
From 3	—	—	—	—	May 13, 2019	3.04M	—	—	—	View

RSLSobalon therapeutics inc

Updated: Aug 08, 2019VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.78	437.50K	$4.00	$1.75M	Aug 08, 2019	1.00M	Purchase	—	Aug 06	View
From 4	0.41	1.65M	$1.82	$3.00M	Aug 27, 2018	5.63M	Purchase	—	Aug 23	View
From 4	0.08	3.63K	—	—	Oct 14, 2016	49.57K	Options	—	Oct 12	View
From 4	0.06	213.04K	—	—	Oct 14, 2016	3.99M	Options	—	Oct 12	View
From 3	—	—	—	—	Oct 05, 2016	—	—	—	—	View
From 3	—	—	—	—	Oct 05, 2016	—	—	—	—	View

BNGObionano genomics, inc.

Updated: Aug 27, 2018VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.96	183.36K	$4.59	—	Aug 27, 2018	6.89K	Options	—	Aug 23	View
From 4	-0.91	24.68M	$5.36	$1.64M	Aug 27, 2018	2.48M	Buy-Options	—	Aug 23	View
From 3	—	—	—	—	Aug 21, 2018	—	—	—	—	View
From 3	—	—	—	—	Aug 21, 2018	140.00	—	—	—	View
From 3	—	—	—	—	Aug 21, 2018	—	—	—	—	View

dicerna pharmaceuticals inc

Updated: Dec 20, 2017

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.92	12.36K	$3.19	—	Dec 20, 2017	25.73K	Options	—	Dec 18	View
From 4	0.92	1.67M	$3.19	—	Dec 20, 2017	3.47M	Options	—	Dec 18	View
From 4	—	368.00	$100.00	$36.80K	Apr 12, 2017	368.00	Purchase	—	Apr 11	View
From 4	—	49.63K	$100.00	$4.96M	Apr 12, 2017	49.63K	Purchase	—	Apr 11	View
From 4	—	—	—	—	Feb 04, 2014	1.79M	Options	—	Feb 04	View
From 3	—	—	—	—	Jan 29, 2014	—	—	—	—	View

ocera therapeutics, inc.

Updated: Dec 13, 2017

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	47.96K	—	—	Dec 13, 2017	—	Disposition	—	Dec 11	View
From 4	-1.00	15.73K	—	—	Dec 13, 2017	—	Disposition	—	Dec 11	View
From 4	-1.00	1.90M	—	—	Dec 13, 2017	—	Disposition	—	Dec 11	View
From 4	-1.00	7.33K	—	—	Dec 13, 2017	—	Disposition	—	Dec 11	View
From 4	-1.00	988.28K	—	—	Dec 13, 2017	—	Disposition	—	Dec 11	View
From 4/A	0.87	1.33M	$6.03	$8.00M	Jul 31, 2013	2.92M	Purchase	—	Jul 15	View
From 3/A	—	—	—	—	Jul 31, 2013	1.59M	—	—	—	View
From 4	0.85	1.33M	$6.03	$8.00M	Jul 16, 2013	2.96M	Purchase	—	Jul 15	View
From 3	—	—	—	—	Jul 16, 2013	1.63M	—	—	—	View

colucid pharmaceuticals, inc.

Updated: Sep 13, 2016

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	1.94M	—	—	Sep 13, 2016	—	Disposition	—	Sep 09	View
From 4	-0.07	245.00	$8.45	-$2.07K	Aug 03, 2016	3.04K	Sale	—	Aug 01 - 03	View
From 4	-0.07	153.03K	$8.45	-$1.29M	Aug 03, 2016	1.94M	Sale	—	Aug 01 - 03	View
From 4	-0.07	149.76K	$6.96	-$1.04M	May 02, 2016	2.10M	Sale	—	Apr 28	View
From 4	-0.07	235.00	$6.96	-$1.64K	May 02, 2016	3.28K	Sale	—	Apr 28	View
From 4	—	—	—	—	May 11, 2015	3.52K	Options	—	May 11	View
From 4	—	—	—	—	May 11, 2015	2.25M	Options	—	May 11	View
From 3	—	—	—	—	May 05, 2015	—	—	—	—	View
From 3	—	—	—	—	May 05, 2015	43.67K	—	—	—	View

SNDXsyndax pharmaceuticals inc

Updated: Mar 08, 2016VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Mar 08, 2016	13.93K	Options	—	Mar 08	View
From 4	—	—	—	—	Mar 08, 2016	1.74M	Options	—	Mar 08	View
From 4	—	—	—	—	Mar 08, 2016	5.64K	Options	—	Mar 08	View
From 4	—	—	—	—	Mar 08, 2016	761.06K	Options	—	Mar 08	View
From 3	—	—	—	—	Mar 02, 2016	—	—	—	—	View
From 3	—	—	—	—	Mar 02, 2016	—	—	—	—	View
From 3	—	—	—	—	Mar 02, 2016	—	—	—	—	View
From 3	—	—	—	—	Mar 02, 2016	—	—	—	—	View
From 3	—	—	—	—	Mar 02, 2016	13.56K	—	—	—	View

EVOKevoke pharma inc

Updated: May 27, 2016VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.36	5.88K	$4.70	-$27.64K	May 27, 2016	10.33K	Sale	—	May 26	View
From 4	-0.36	344.12K	$4.70	-$1.62M	May 27, 2016	606.28K	Sale	—	May 26	View
From 4	-0.01	82.00	$5.07	-$415.42	Apr 27, 2016	16.21K	Sale	—	Apr 25 - 27	View
From 4	-0.01	5.09K	$5.07	-$25.85K	Apr 27, 2016	950.40K	Sale	—	Apr 25 - 27	View
From 4	-0.04	708.00	$5.35	-$3.79K	Apr 21, 2016	16.29K	Sale	—	Apr 19 - 20	View
From 4	-0.04	41.48K	$5.35	-$222.01K	Apr 21, 2016	955.50K	Sale	—	Apr 19 - 20	View
From 4	-0.00	75.00	$5.22	-$391.50	Apr 13, 2016	17.00K	Sale	—	Apr 11	View
From 4	-0.00	4.35K	$5.22	-$22.70K	Apr 13, 2016	996.98K	Sale	—	Apr 11	View
From 4	-0.05	874.00	$5.28	-$4.61K	Apr 08, 2016	17.07K	Sale	—	Apr 06 - 08	View
From 4	-0.05	51.00K	$5.28	-$269.24K	Apr 08, 2016	1.00M	Sale	—	Apr 06 - 08	View
From 4	-0.01	202.00	$7.02	-$1.42K	Aug 20, 2015	17.95K	Sale	—	Aug 18	View
From 4	-0.01	11.84K	$7.02	-$83.09K	Aug 20, 2015	1.05M	Sale	—	Aug 18	View
From 4	-0.05	50.16K	$7.29	-$365.67K	Apr 16, 2015	1.06M	Sale	—	Apr 14 - 16	View
From 4	-0.05	857.00	$7.29	-$6.25K	Apr 16, 2015	18.15K	Sale	—	Apr 14 - 16	View
From 4	—	—	—	—	Sep 30, 2013	1.14M	Options	—	Sep 30	View
From 3	—	—	—	—	Sep 24, 2013	5.25K	—	—	—	View

GKOSglaukos corp

Updated: Jul 01, 2015VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Jul 01, 2015	876.08K	Options	—	Jun 30	View
From 4	—	—	—	—	Jul 01, 2015	6.50K	Options	—	Jun 30	View
From 3	—	—	—	—	Jun 24, 2015	—	—	—	—	View
From 3	—	—	—	—	Jun 24, 2015	—	—	—	—	View
From 3	—	—	—	—	Jun 24, 2015	63.20K	—	—	—	View

LIFEatyr pharma inc

Updated: May 12, 2015VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.88	94.46K	—	—	May 12, 2015	13.41K	Options	—	May 12	View
From 4	-0.88	12.73M	—	—	May 12, 2015	1.81M	Options	—	May 12	View
From 3	—	—	—	—	May 06, 2015	—	—	—	—	View
From 3	—	—	—	—	May 06, 2015	—	—	—	—	View
From 3	—	—	—	—	May 06, 2015	12.57K	—	—	—	View

regado biosciences inc

Updated: May 06, 2015

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	May 06, 2015	47.61K	—	—	—	View
From 3	—	—	—	—	May 06, 2015	3.28M	—	—	—	View
From 3	—	—	—	—	Aug 21, 2013	53.10K	—	—	—	View

ATRAatara biotherapeutics, inc.

Updated: Oct 21, 2014VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.13	1.84K	$11.00	—	Oct 21, 2014	15.89K	Purchase	—	Oct 21	View
From 4	0.13	248.16K	$11.00	—	Oct 21, 2014	2.14M	Purchase	—	Oct 21	View
From 3	—	—	—	—	Oct 15, 2014	—	—	—	—	View
From 3	—	—	—	—	Oct 15, 2014	—	—	—	—	View

ALDXaldeyra therapeutics, inc.

Updated: May 07, 2014VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	May 07, 2014	1.97M	Options	—	May 07	View
From 4	1.37	5.33K	—	—	May 05, 2014	9.21K	Options	—	May 01	View
From 4	0.43	589.41K	$6.58	$136.32	May 05, 2014	1.95M	Options	—	May 01	View
From 3	—	—	—	—	May 01, 2014	—	—	—	—	View
From 3	—	—	—	—	May 01, 2014	—	—	—	—	View
From 3	—	—	—	—	May 01, 2014	10.36K	—	—	—	View

otonomy, inc.

Updated: Aug 18, 2014

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.02	277.00	$12.40	-$19.42	Aug 18, 2014	11.72K	Options	—	Aug 18	View
From 4	-0.02	37.22K	$12.40	-$17.55	Aug 18, 2014	1.58M	Options	—	Aug 18	View
From 3	—	—	—	—	Aug 12, 2014	—	—	—	—	View
From 3	—	—	—	—	Aug 12, 2014	—	—	—	—	View

EVFMneothetics, inc.

Updated: Dec 10, 2014VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4/A	-0.82	212.39K	$11.27	-$37.56K	Dec 10, 2014	48.03K	Options	—	Nov 25	View
From 4/A	-0.81	13.43M	$11.86	-$2.20M	Dec 10, 2014	3.09M	Buy-Options	—	Nov 25	View
From 3/A	—	—	—	—	Nov 26, 2014	—	—	—	—	View
From 3/A	—	—	—	—	Nov 26, 2014	—	—	—	—	View
From 4	-0.82	212.39K	$11.27	-$37.56K	Nov 26, 2014	48.02K	Options	—	Nov 25	View
From 4	-0.81	13.43M	$11.86	-$2.20M	Nov 26, 2014	3.09M	Buy-Options	—	Nov 25	View
From 3	—	—	—	—	Nov 19, 2014	—	—	—	—	View
From 3	—	—	—	—	Nov 19, 2014	3.93K	—	—	—	View
From 3	—	—	—	—	Nov 19, 2014	—	—	—	—	View

durata therapeutics, inc.

Updated: Nov 18, 2014

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	3.01M	—	—	Nov 18, 2014	—	Disposition	—	Nov 17	View
From 4	-1.00	22.31K	—	—	Nov 18, 2014	—	Disposition	—	Nov 17	View
From 4	-1.00	6.25K	—	—	Nov 18, 2014	—	Disposition	—	Nov 17	View
From 4	-1.00	8.57K	—	—	Nov 18, 2014	—	Disposition	—	Nov 17	View
From 4	—	8.57K	—	—	May 22, 2014	8.58K	Grant	—	May 21	View
From 4	0.35	784.31K	$9.00	—	Jul 24, 2012	3.03M	Purchase	—	Jul 24	View
From 3	—	—	—	—	Jul 18, 2012	6.25K	—	—	—	View

ALIMalimera sciences inc

Updated: Jan 17, 2014VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.08	296.76K	$6.39	-$1.90M	Jan 17, 2014	3.59M	Sale	Scheduled	Jan 15 - 16	View
From 4	-0.08	3.24K	$6.39	-$20.70K	Jan 17, 2014	34.91K	Sale	Scheduled	Jan 15 - 16	View
From 4	-0.00	114.00	$5.01	-$571.14	Jun 24, 2013	38.15K	Sale	Scheduled	Jun 20	View
From 4	-0.00	10.52K	$5.01	-$52.69K	Jun 24, 2013	3.89M	Sale	Scheduled	Jun 20	View
From 4	-0.02	603.00	$5.39	-$3.25K	Jun 20, 2013	38.26K	Sale	Scheduled	Jun 18 - 19	View
From 4	-0.01	55.28K	$5.39	-$297.83K	Jun 20, 2013	3.90M	Sale	Scheduled	Jun 18 - 19	View
From 4	-0.03	1.38K	$5.29	-$7.32K	Jun 18, 2013	38.86K	Sale	Scheduled	Jun 14 - 17	View
From 4	-0.03	126.71K	$5.29	-$669.84K	Jun 18, 2013	3.95M	Sale	Scheduled	Jun 14 - 17	View
From 4	-0.00	59.00	$5.00	-$295.00	Jun 13, 2013	40.25K	Sale	Scheduled	Jun 11	View
From 4	-0.00	5.34K	$5.00	-$26.68K	Jun 13, 2013	4.08M	Sale	Scheduled	Jun 11	View
From 4	-0.01	483.00	$4.60	-$2.22K	May 17, 2013	40.31K	Sale	—	May 15 - 16	View
From 4	-0.01	44.24K	$4.60	-$203.68K	May 17, 2013	4.09M	Sale	—	May 15 - 16	View
From 4	-0.14	688.05K	$8.04	-$55.59K	Jun 03, 2011	4.19M	Sale	—	Jun 02	View
From 4	0.08	378.03K	$11.00	—	Apr 27, 2010	4.88M	Purchase	—	Apr 27	View
From 3	—	—	—	—	Apr 21, 2010	—	—	—	—	View

VCYTveracyte, inc.

Updated: Sep 12, 2014VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.10	300.00K	—	—	Sep 12, 2014	2.76M	Disposition	—	Sep 10	View
From 4	—	—	—	—	Nov 04, 2013	3.09M	Options	—	Nov 04	View
From 3	—	—	—	—	Oct 29, 2013	—	—	—	—	View

achaogen inc

Updated: Mar 11, 2014

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Mar 11, 2014	—	—	—	—	View

cadence pharmaceuticals inc

Updated: Jan 29, 2013

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4/A	-0.02	154.55K	$5.43	-$839.30K	Jan 29, 2013	8.06M	Sale	Scheduled	Jan 24 - 25	View
From 3	—	—	—	—	Oct 24, 2006	27.50K	—	—	—	View

clovis oncology, inc.

Updated: Jun 05, 2013

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.06	2.78K	$64.58	-$179.47K	Jun 05, 2013	44.03K	Sale	—	Jun 04	View
From 4	-0.06	159.19K	$64.58	-$10.28M	Jun 05, 2013	2.58M	Sale	—	Jun 04	View
From 4	-0.08	250.00K	$24.59	-$6.15M	Mar 06, 2013	2.74M	Sale	—	Mar 04 - 06	View
From 4	-0.08	4.20K	$24.59	-$103.30K	Mar 06, 2013	46.81K	Sale	—	Mar 04 - 06	View
From 4	-0.44	2.36M	$13.00	—	Nov 21, 2011	3.04M	Buy-Options	—	Nov 21	View
From 3	—	—	—	—	Nov 15, 2011	32.76K	—	—	—	View

TNDMtandem diabetes care inc

Updated: Nov 19, 2013VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.06	242.11K	—	—	Nov 19, 2013	3.60M	Options	—	Nov 19	View
From 3	—	—	—	—	Nov 13, 2013	—	—	—	—	View

celator pharmaceuticals inc

Updated: Jan 15, 2013

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Jan 15, 2013	2.24M	—	—	—	View

orexigen therapeutics, inc.

Updated: Dec 22, 2011

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.37	938.29K	$7.97	$7.48M	Dec 22, 2011	3.49M	Purchase	—	Dec 22	View
From 4	0.06	138.10K	$7.54	$1.04M	Dec 21, 2009	2.55M	Purchase	—	Dec 17 - 18	View
From 4	0.02	50.00K	$6.75	$337.50K	Nov 25, 2009	2.41M	Purchase	—	Nov 24	View
From 4	0.20	400.00K	$6.93	$2.77M	Nov 24, 2009	2.36M	Purchase	—	Nov 20 - 23	View
From 4	0.03	62.00K	$6.90	$427.80K	Nov 16, 2009	1.96M	Purchase	—	Nov 12	View
From 4	0.08	138.00K	$6.93	$956.34K	Nov 12, 2009	1.90M	Purchase	—	Nov 10 - 11	View
From 4	0.01	13.78K	$7.73	$106.55K	Aug 19, 2009	1.76M	Purchase	—	Aug 18	View
From 4	0.05	89.43K	$7.75	$692.66K	Aug 18, 2009	1.75M	Purchase	—	Aug 14 - 17	View
From 4	0.33	413.00K	$8.00	$3.30M	Aug 14, 2009	1.66M	Purchase	—	Aug 12 - 13	View
From 4	0.09	104.30K	$7.60	$792.68K	Aug 13, 2009	1.24M	Purchase	—	Aug 11	View
From 4	1.33	650.00K	$7.50	$4.88M	Jul 24, 2009	1.14M	Purchase	—	Jul 23	View
From 4	—	490.30K	$4.70	$2.30M	Dec 10, 2008	490.30K	Purchase	—	Dec 08 - 09	View
From 3/A	—	—	—	—	Aug 20, 2008	4.98K	—	—	—	View
From 3	—	—	—	—	Nov 29, 2007	1.96K	—	—	—	View

zogenix, inc.

Updated: Sep 20, 2011

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.53	3.50M	$2.00	$7.00M	Sep 20, 2011	10.09M	Purchase	—	Sep 16	View
From 4	0.55	2.35M	$4.00	—	Dec 01, 2010	6.60M	Purchase	—	Nov 29	View
From 3	—	—	—	—	Nov 22, 2010	11.00K	—	—	—	View

volcano corp

Updated: Jun 09, 2008

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.06	3.76K	—	—	Jun 09, 2008	61.86K	Acquisition	—	Apr 24 - 28	View
From 4	28.67	53.38K	—	—	Sep 12, 2007	55.24K	Acquisition	—	Sep 12	View
From 3/A	—	—	—	—	Aug 10, 2007	4.73K	—	—	—	View
From 3	—	—	—	—	Jun 14, 2007	1.86K	—	—	—	View

VNDAvanda pharmaceuticals inc.

Updated: Dec 13, 2006VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.23	584.29K	$25.62	-$330.50K	Dec 13, 2006	2.00M	Sale	—	Dec 12	View
From 4	-0.20	623.33K	—	—	Nov 03, 2006	2.55M	Disposition	—	Nov 03	View
From 4	-0.70	7.40M	—	—	Apr 18, 2006	3.20M	Options	—	Apr 18	View
From 3	—	—	—	—	Apr 12, 2006	—	—	—	—	View

novacea inc

Updated: May 09, 2006

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	May 09, 2006	100.36K	—	—	—	View

somaxon pharmaceuticals, inc.

Updated: Dec 22, 2006

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.25	567.85K	$13.52	-$87.33K	Dec 22, 2006	1.75M	Sale	—	Dec 21	View
From 4	-0.20	6.46K	$13.03	-$84.16K	Sep 20, 2006	25.84K	Sale	—	Sep 18	View
From 4	-0.20	565.16K	—	—	Sep 14, 2006	2.29M	Disposition	—	Sep 13	View
From 4	-0.83	14.45M	—	—	Dec 20, 2005	2.89M	Options	—	Dec 20	View
From 3	—	—	—	—	Dec 14, 2005	19.17K	—	—	—	View

northstar neuroscience, inc.

Updated: May 04, 2006

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	May 04, 2006	3.33K	—	—	—	View

onyx pharmaceuticals inc

Updated: Jul 28, 2005

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	668.00	—	—	Jul 28, 2005	668.00	Acq/Dis	—	Jul 28	View
From 4	—	10.00K	—	—	Feb 08, 2005	10.00K	Grant	—	Feb 04	View
From 4	—	5.00K	—	—	Feb 09, 2004	5.00K	Grant	—	Feb 04	View

nuvasive inc

Updated: May 12, 2004

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	May 12, 2004	8.00K	—	—	—	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions